Evidence map›Paper›PMID 35801212›Full record

ArticleFrontiers in medicine2022

Chin-Chou Huang, Chia-Min Chung, Chih-Yu Yang, Hsin-Bang Leu, Po-Hsun Huang, Liang-Yu Lin, Tao-Cheng Wu, Shing-Jong Lin, Wen-Harn Pan, Jaw-Wen Chen

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Evaluation of the efficacy ofFrontiers in pharmacology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Chin-Chou HuangDivision of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Chia-Min ChungCenter for Drug Abuse and Addiction, China Medical University Hospital, Taichung, Taiwan.
Chih-Yu YangSchool of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Hsin-Bang LeuDivision of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Po-Hsun HuangDivision of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Liang-Yu LinSchool of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Tao-Cheng WuDivision of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Shing-Jong LinDivision of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
Wen-Harn PanInstitute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.
Jaw-Wen ChenDivision of Cardiology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
National Yang Ming Chiao Tung University · TWTaipei Veterans General Hospital · TWChina Medical University Hospital · TWNational Taiwan University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Methods: Participants from three non-diabetic hypertensive cohorts, including young-onset hypertension (cohort 1, Results: In cohort 1, Conclusion:

Indexed as

glomerular filtration rateglomerular hyperfiltrationhypertensionhypertensive nephropathySLC12A3

Identifiers

PMID35801212
PMCPMC9253539
OpenAlexW4283218969

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.